ArticleHepatology communications2019

Transjugular Intrahepatic Portosystemic Shunt: A Possible Risk Factor for Direct-Acting Antiviral Treatment Failure in Patients With Hepatitis C?

Felix Piecha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.